Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitis

Gut

Volumn 32, Issue 4, 1991, Pages 424-429

  Jeffrey, G P ^a   Reed, W D ^a   Carrello, S ^b   Shilkin, K B ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHOLECYSTITIS; CLINICAL ARTICLE; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

ADULT; AGED; CHOLANGITIS, SCLEROSING; CHOLECYSTITIS; FEMALE; GALLBLADDER; HUMAN; IMMUNOENZYME TECHNIQUES; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES;

EID: 0025852074     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.32.4.424     Document Type: Article

References (15)

1. Sherlock S. The syndrome of disappearing intrahepatic bile ducts. Lancet 1987; ii: 493-6.
2. Chapman RW, Marborgh BA, Rhodes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 1980; 21: 870-7.
3. Jeffrey GP, Reed WD, Laurence BH, Shilkin KB. Primary sclerosing cholangitis - a clinical and immunopathological review of 21 cases. J Gastroenterol Hepatol 1990; 5: 135-40.
4. Bodenheimer HC, LaRusso NF, Thayer WR, Charland C, Staples P, Ludwig J. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983; 3: 150-4.
5. Alberti-Flor JJ, Medina M, Jeffers L, Schultz DR, Schiff ER. Elevated levels of immunoglobulins and immune complexes in the bile of patients with primary sclerosing cholangitis. Am J Gastroenterol 1986; 81: 325-8.
6. Brinch L, Triesberg P, Schrumpf E, Akesson I. The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis. Scand J Gastroenterol 1982; 17: 523-7.
7. Minuk GY, Angus M, Brickman CM, et al. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology 1985; 88: 166-70.
8. MacFarlane IG, Wojcicka BM, Tsantoulas DC, Portmann BL, Eddleston ALWF, Williams R. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis and other chronic liver diseases. Gastroenterology 1979; 76: 1333-40.
9. Whiteside TL, Lasky S, Si L, Van Thiel DH. Immunological analysis of mononuclear cells in liver tissue and blood of patients with primary sclerosing cholangitis. Hepatology 1985; 5: 468-74.
10. Magrin S, Nouri-Aria KT, Donaldson PT, et al. The relationship between HLA-DR3 and T-cell regulation of immunoglobulin production in primary sclerosing cholangitis. Clin Immunol Immunopathol 1989; 50: 205-12.
11. Chapman RW, Kelly PMA, Heryet A, Jewell DP, Fleming KA. Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 1988; 29: 422-7.
12. Ludwig J, MacCarty RL, LaRusso NF, Krom RAF, Wiesner RH. Intrahepatic cholangiectasis and large duct obstruction in primary sclerosing cholangitis. Hepatology 1986; 6: 560-8.
13. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Primary sclerosing cholangitis. N Engl J Med 1984; 310: 899-903.
14. Schwartz SI, Dale WA. Primary sclerosing cholangitis. Review and report of six cases. Arch Surg 1958; 77: 439-50.
15. Thorpe MEC, Scheuer PJ, Sherlock S. Primary sclerosing cholangitis, the biliary tree and ulcerative colitis. Gut 1967; 8: 435-48.